0.057 USD
-0.07 (-55.98%)
0.0399 USD
-0.02 (-30%)
ChartMill assigns a Buy % Consensus number of 83% to CDAK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.18. This target is 16005.26% above the current price.
CDAK was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CDAK.
In the previous month the buy percentage consensus was at a similar level.
CDAK was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-07 | Goldman Sachs | Maintains | Neutral |
| 2022-09-01 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2022-07-05 | Goldman Sachs | Maintains | Buy |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-02-22 | Wedbush | Maintains | Outperform |
| 2022-02-11 | Goldman Sachs | Initiate | Buy |
CODIAK BIOSCIENCES INC / CDAK FAQ
What is the average price target for CODIAK BIOSCIENCES INC (CDAK) stock?
7 analysts have analysed CDAK and the average price target is 9.18 USD. This implies a price increase of 16005.26% is expected in the next year compared to the current price of 0.057.
What is the consensus rating for CODIAK BIOSCIENCES INC (CDAK) stock?
The consensus rating for CODIAK BIOSCIENCES INC (CDAK) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed CODIAK BIOSCIENCES INC (CDAK)?
The number of analysts covering CODIAK BIOSCIENCES INC (CDAK) is 7.